Department of Laboratory Medicine, Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Chongming Branch, Shanghai, China.
Department of Orthopedics, The Second People' Hospital of Hefei, Hefei, Anhui, China.
Clin Chim Acta. 2020 Nov;510:1-4. doi: 10.1016/j.cca.2020.06.040. Epub 2020 Jun 27.
This study mainly focused on the very serious COVID-19 epidemic situation at present and provided a new insight for the treatment and monitor of patients with COVID-19. Through this meta-analysis, we could draw a conclusion that less expression of blood CD4 and CD8 T cells count might reflect the severity of infection and often accompanied by a poor prognosis. Hence, we inferred blood CD4+ and CD8+ T cells count could be a promising biomarker for disease assessment and monitor of patients with COVID-19.
本研究主要针对当前非常严重的 COVID-19 疫情，为 COVID-19 患者的治疗和监测提供了新的视角。通过这项荟萃分析，我们可以得出结论，血液中 CD4 和 CD8 T 细胞计数的减少可能反映了感染的严重程度，并且常常伴有不良预后。因此，我们推断血液 CD4+和 CD8+T 细胞计数可能是 COVID-19 患者疾病评估和监测的有前途的生物标志物。
Zotero 插件